ASSOCIATION OF SERUM MAGNESIUM LEVELS WITH FASTING PLASMA GLUCOSE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS ON METFORMIN OR PIOGLITAZONE
Keywords:
serum magnesium level, fasting plasma, glucose, type 2 diabetes mellitusAbstract
INTRODUCTION
The aim of this study is to analyze the association between serum magnesium level and fasting plasma glucose in patients with type 2 diabetes mellitus (DM) who had taken metformin or pioglitazone.
METHODOLOGY
Serum magnesium level and fasting plasma glucose were examined from a total of 41 patients whose type 2 diabetes was controlled with metformin ≥750 mg/day for at least 3 weeks or pioglitazone ≥15 mg/day for at least 4 weeks with a body mass index (BMI) of <30 kg/m2 . Fasting plasma glucose was analyzed using Roche/Hitachi Cobas C System. Serum magnesium level was analyzed using Roche/Hitachi Cobas C311/501 System.
RESULTS
The mean value of serum magnesium levels was 2.04±0.19 mg/dL. The median of fasting plasma glucose was 131±40, 85 mg/dL. The lower level of the serum magnesium had a significant correlation with fasting plasma glucose.
CONCLUSION
There is a significant negative correlation between the serum magnesium levels and fasting plasma glucose in type 2 DM on metformin or pioglitazone.
Downloads
References
*
Downloads
Published
How to Cite
Issue
Section
License
The full license text is available at: http://creativecommons.org/licenses/by-nc/3.0/legalcode.
To request permission to translate, reproduce, download, or use articles or images for commercial reuse or business purposes from the Journal of the ASEAN Federation of Endocrine Societies (JAFES), kindly complete the Permission Request for Use of Copyrighted Material Form and email jafes@asia.com or jafes.editor@gmail.com.
A written agreement will be issued to the requester once permission has been granted.





